Compliance / Research Use Only

Marketing for RUO (Research Use Only) Brands

This page is a compliance reference for brands operating in the RUO (Research Use Only) product category. It is not a commercial pitch. RUO is one of the most misunderstood categories in wellness marketing, and most of the advice circulating in founder communities either skips the regulatory framework entirely or misrepresents what Meta, Google, and the FTC actually permit.

Researcher pipetting a sample in a laboratory, representing the research use only product category

An honest set of constraints

Raging Agency is the health and wellness digital marketing agency behind $7M+ in restricted-category wellness sales. We work with RUO brands inside a specific compliance framework. That framework starts with understanding what RUO actually is, what it is not, and what the marketing playbook realistically looks like when Meta and Google will not run paid ads for the category and the FTC has clear positions on what can and cannot be claimed.

If you run a RUO brand and you are looking for an agency to run scaled Meta and Google paid media on your products, this page is going to read as an honest set of constraints instead of a sales pitch. Take it in that spirit.

What RUO actually means

RUO stands for Research Use Only. It is a labeling designation, not a product category. Products labeled RUO are sold for research purposes only, are labeled "not for human consumption," and are not FDA-approved or FDA-cleared for any human use.

The category exists as a regulatory pathway for compounds that are not FDA-approved for human use but that have legitimate research applications. Research chemistry, in-vitro assay work, animal studies, and academic research contexts all consume RUO-labeled materials. The RUO designation preserves the ability to manufacture and sell these compounds without running the FDA drug approval process required for human-use pharmaceuticals.

In practice, a subset of the RUO market has grown up around consumer-facing brands selling RUO-labeled peptides, SARMs, and related research chemicals into what everyone in the market understands to be a human-consumption end use. That gap between the label and the actual end use is the source of both the category's growth and its regulatory exposure.

The FDA's position on RUO products marketed to consumers is not ambiguous. When a RUO product is marketed with any implication of human use, dosing, or therapeutic benefit, the FDA can treat it as an unapproved new drug and move to enforcement. FDA warning letters to RUO brands making human-consumption implications have been a recurring pattern since 2015 and have picked up since 2023.

The RUO product category

The most common products sold under the RUO label in consumer-facing markets include peptides such as BPC-157, TB-500, growth hormone secretagogues, and adjacent research peptides, SARMs (selective androgen receptor modulators) including compounds like ostarine, ligandrol, and RAD-140, and various research chemicals adjacent to biohacking and performance categories.

Every one of these compounds sits in its own regulatory context. Some SARMs have been the subject of FDA warning letters and USADA prohibited-substance listings. Some peptides have been federally scheduled or restricted in specific formulations. The regulatory posture keeps shifting as compounds move from research contexts into consumer markets and back.

A RUO brand's compliance posture depends on the specific compounds in its product line, the geographic markets it ships to, the claims it makes on packaging and marketing materials, and the enforcement priorities of both the FDA and FTC at any given moment.

Why Meta and Google will not run paid ads for RUO products

Both Meta and Google explicitly prohibit paid advertising for RUO products in their public policy documents.

Meta's Unsafe Substances policy and its Adult Health policy together capture most RUO product categories as prohibited advertising. Even where a specific compound is not named in Meta's policy, the framing that any product not labeled for human consumption cannot be advertised for use by humans applies. Trying to run RUO paid social by wrapping the ad in "research applications" language gets flagged during policy review and eventually triggers account restrictions once the review team traces the landing page to a consumer-facing checkout.

Google's Healthcare and Medicines policy, its Unapproved Pharmaceuticals policy, and its Dangerous Products policy together capture the RUO category. Google Ads accounts running RUO products get restricted fast, and the appeal process rarely produces a different outcome because the policy is not applied inconsistently.

The occasional workaround, running a "brand awareness" or "content" campaign that does not name the product, breaks down as soon as the platform reviewer follows the landing page path back to a RUO product catalog. Sustained paid social on RUO products is not a compliant strategy inside 2026 platform policy.

If your Meta assets have already been restricted, see our account recovery guides for Instagram, Facebook Pages, ad accounts, and Business Manager.

The compliant marketing playbook for RUO brands

Because Meta and Google are largely closed to the category, the playbook that works for RUO brands looks nothing like the playbook that works for direct-to-consumer wellness DTC.

Organic SEO

SEO is the single largest channel for RUO brands operating inside a compliant framework. Educational content about specific compounds framed as research applications, category-explainer content, safety information, and buyer-guide content can build organic search traffic that Meta and Google will not deliver through paid channels.

The compliance discipline on RUO SEO content is strict. Content cannot recommend dosing for humans, cannot make therapeutic claims, cannot describe the compound's effects in humans, and cannot frame the product as a treatment for any condition. Content that stays inside those constraints, describing what a compound is, its known research context, and its regulatory status, can rank and pull traffic without triggering FTC exposure.

Technical SEO for RUO brands also has to survive the reality that search engines have their own policies on health-related content in restricted categories. RUO content that gets flagged in Google's medical content quality reviews can lose organic visibility, so the content quality bar is higher than in unrestricted categories.

Affiliate networks

Affiliate marketing is the second-largest channel for RUO brands. Compliance-fluent affiliate programs recruit affiliates who understand the category, provide content guidelines that hold affiliate copy inside FTC and FDA boundaries, and monitor affiliate output for drift into non-compliant claims. Compliant affiliate programs pay on qualified transactions, provide clear disclosure requirements, and terminate affiliates who make prohibited claims.

Uncompliant affiliate programs, the ones that recruit anyone with a following and pay on volume without policing content, eventually surface as regulatory liability for the brand. FTC actions have targeted affiliate programs where the sponsoring brand did not police its affiliates' claims, and the brand carries the exposure even when the specific claim came from an affiliate.

Influencer partnerships

Influencer partnerships work in the RUO category subject to the same compliance discipline as affiliate. Creators in the biohacking, longevity, and adjacent categories can partner with RUO brands, disclose the material connection under the FTC Endorsement Guides August 2023 update, and speak to the category without making prohibited claims about specific outcomes, dosing, or human therapeutic effects.

The compliance envelope is tighter than most creators are used to. Brands running influencer programs in this category need to brief creators on what can and cannot be said, provide pre-approved talking points, and review creator content before it publishes.

Email marketing

Email is one of the highest-leverage channels for RUO brands because it operates outside the platform ad review layer. Compliant RUO email marketing focuses on category education, product information framed inside the research-use context, new product announcements, and customer service touchpoints. It does not make therapeutic claims, does not recommend dosing, and does not describe human outcomes.

Well-run RUO email programs deliver the LTV amplification that RUO brands need to offset the higher friction on the acquisition side.

Community-driven growth

The RUO category has substantial community infrastructure across Reddit, Discord, and adjacent platforms. Brands that participate authentically, contribute educational content, and build reputation over time generate a category-native discovery layer that paid media cannot replicate. Brands that treat these communities as ad inventory get banned and lose the channel.

The FTC line

The Federal Trade Commission's position on RUO brand marketing is that any claim made in advertising has to be substantiated by competent and reliable scientific evidence, that health claims about products not FDA-approved for the represented use are per se problematic, and that the RUO label does not shield the brand from FTC enforcement when the marketing represents the product as a therapeutic.

The specific claims the FTC treats as prohibited in RUO marketing:

  • Medical claims. Any statement that the product treats, cures, prevents, or mitigates a disease or condition.
  • Dosing instructions for humans. Any recommendation on how a human should consume the product.
  • Human-consumption implications. Any framing that implies the product is intended for or safe for human use, including before-and-after imagery, human user testimonials referencing personal use, or content describing the compound's effects in humans.
  • Therapeutic outcome claims. Any promise about outcomes the product will produce in a human user.

The line between compliant and non-compliant content is not intuitive to founders coming from other categories. Content saying "BPC-157 is a synthetic peptide studied in animal models for wound healing research" is generally compliant. Content saying "BPC-157 heals injuries in 4 weeks" is not. The first describes the compound's research context. The second makes a therapeutic claim about a human outcome.

What Raging Agency does for RUO brands

Raging Agency works with RUO brands inside a specific compliance-first framework:

  • Compliant content marketing. SEO content, category education, and brand-authority publishing that keeps the brand inside FDA and FTC boundaries while building the organic discovery layer paid social cannot deliver.
  • Affiliate program design. Structuring compliant affiliate programs with content guidelines, disclosure requirements, monitoring workflows, and creator vetting to shield the brand from downstream exposure.
  • Organic SEO for restricted categories. Technical SEO, on-page optimization, schema markup, and content strategy calibrated for search engine policies on health-related restricted content.
  • Email lifecycle. Compliant email nurture, customer retention, LTV amplification, and post-purchase communication.
  • Compliance framework consulting. Helping the brand's leadership understand where the FDA, FTC, Meta, and Google lines sit, and building the internal review workflow that keeps marketing compliant as the brand scales.

What Raging Agency will not do for RUO brands

Honest constraints are the frame this page runs under, so the constraints are explicit:

  • We will not make medical claims for RUO products. We will not produce content that describes the compound's therapeutic effects in humans, recommends dosing, or promises outcomes.
  • We will not run paid Meta or paid Google ads for RUO products. The category is prohibited on both platforms and working around the prohibitions creates exposure for the brand that outweighs the short-term acquisition value.
  • We will not produce before-and-after imagery, human user testimonials referencing personal consumption, or any creative pattern that implies the product is for human use in violation of the RUO label.
  • We will not build affiliate or influencer programs that operate outside FTC disclosure requirements or that recruit creators the brand cannot vet.

These constraints are the boundary between compliant marketing that scales the brand durably and non-compliant marketing that builds short-term revenue and long-term regulatory exposure.

Buyer profile fit

Raging Agency screens RUO engagements carefully. The profile we work best with:

  • RUO brand with existing revenue above $200,000 per month, primarily driven by organic and word-of-mouth channels, looking to formalize the marketing operation.
  • Product line clearly labeled for research use only, with legal review of packaging, product labeling, and website disclosures already completed.
  • Leadership committed to compliant marketing rather than looking for an agency to help them work around platform prohibitions or FDA rules.
  • Willingness to invest in organic SEO, affiliate program infrastructure, and email lifecycle as the primary growth channels, rather than expecting scaled paid social.
  • Runway of at least 6 months. Organic-first growth in restricted categories compounds slowly. Brands expecting month-one revenue lift from a compliant framework will be disappointed.

We are not the right agency for RUO brands looking to run paid Meta and paid Google, brands making therapeutic claims about their products, or brands treating the RUO label as a marketing convenience rather than a labeling reality.

RUO is one specific corner of the broader wellness advertising compliance landscape. Brands operating in this space should also review:

If you operate a RUO brand and the framework described on this page matches how you already think about your marketing, we are worth a conversation.

Book your free Strategy Call

Frequently asked questions about RUO brand marketing

What does RUO mean?

RUO stands for Research Use Only. It is a labeling designation for products sold for research purposes only, labeled "not for human consumption," and not FDA-approved or FDA-cleared for any human use. The designation preserves a regulatory pathway for compounds that have legitimate research applications outside the FDA drug approval framework.

Can RUO brands advertise on Meta and Google?

Generally no. Both Meta and Google explicitly prohibit paid advertising for RUO products under their unsafe substances, unapproved pharmaceuticals, and adult health policies. Trying to run paid social by framing ads around "research applications" gets flagged during policy review once the landing page traces back to a consumer-facing checkout. Sustained paid media on RUO products is not a compliant strategy.

What marketing channels work for RUO brands?

Organic SEO, compliant affiliate networks, influencer partnerships run inside FTC disclosure requirements, email marketing, and community-driven growth. The playbook is organic-first, affiliate-heavy, and email-native rather than paid-media-driven. Brands scale slower than in unrestricted categories but build a more durable moat when the channels are operated compliantly.

What does the FTC prohibit in RUO marketing?

Medical claims (statements that the product treats, cures, prevents, or mitigates a disease), dosing instructions for humans, human-consumption implications (including before-and-after imagery and human user testimonials that reference personal consumption), and therapeutic outcome claims. The FTC has been active in enforcing against RUO brand marketing that crosses these lines since 2023.

How is RUO product marketing different from compounded medication marketing?

RUO products are labeled for research use only and are not for human consumption, so the marketing is subject to strict prohibitions on any human-use framing. Compounded medications are prescribed through licensed clinical channels under FDA 503A or 503B frameworks and are actively intended for human therapeutic use. The regulatory frameworks are entirely different and the marketing playbooks look nothing alike.

Does Raging Agency work with all RUO brands?

No. We screen for existing revenue above $200,000 per month, clean legal review of packaging and labeling, leadership committed to compliant marketing, and a willingness to invest in organic-first growth channels rather than expecting scaled paid social. We are not the right agency for brands looking to work around platform prohibitions or FDA rules, or for brands making therapeutic claims about RUO products.

About the author

Alex Evans is the founder of Raging Agency, the wellness marketing specialist behind $7M+ in hyperbaric chamber sales and patient acquisition systems for premium med spas, longevity clinics, and biohacking studios. Based in Miami. Connect: @AlexEvans997 on Instagram, author archive.

Operating a RUO brand inside the compliance line?

Book a 20-minute Strategy Call.
We will review your labeling posture, your channel mix, and your claims discipline, and quote a plan if it fits.

Book your free Strategy Call